Can Metformin slow the progression of non-alcoholic steatohepatitis (NASH)? How does it reduce hepatic fat and inflammation in affected patients?
Lakshya KumarExplorer
Can Metformin reduce the progression of non-alcoholic steatohepatitis (NASH)?
Share
Metformin may help in NASH by improving insulin sensitivity and reducing liver inflammation, though its effectiveness specifically for NASH is under debate.
Metformin isn’t primarily used for NASH but can indirectly benefit by reducing insulin resistance and lowering serum insulin levels, which may decrease hepatic steatosis.
While not a standard treatment for NASH, Metformin can aid in controlling hyperglycemia and insulin resistance, potentially mitigating liver fat accumulation and inflammation.